Latest filing published 09 Apr 2026 for Immunovant, Inc..
Filing timeline
BuySaleInsider track record
Jake Bauer: trading record in brief
This profile gathers the share dealings of Jake Bauer across 3 companies, led by MyoKardia, Inc., Immunovant, Inc. and Enliven Therapeutics, Inc. Over a trading history stretching from 29 April 2016 to 7 April 2026, the count stands at 50 filings.
Sales make up the whole of the open-market record (23 sales, €5.8M). The rest of the record consists of 13 share grants and 13 option exercises.
Most recently, on 9 April 2026, the filings show a share grant in Immunovant, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jake Bauer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,880 shares0Common StockSEC:0001764013-26-000044:0
- 25,016 shares0Common StockSEC:0001415889-25-012046:0
- 87,372 sharesCommon StockSEC:0001209191-23-013515:0
- 90,209 sharesCommon StockSEC:0000899243-20-031756:0
- 293 shares@ US$50.410.5% of flowCommon StockSEC:0000899243-20-015248:0
- 10,000 shares@ US$1.510.3% of flowCommon StockSEC:0000899243-20-000730:0
- 2,466 shares@ US$68.453.3% of flowCommon StockSEC:0000899243-20-000730:1
- 6,375 sharesCommon StockSEC:0000899243-20-000382:0
- 10,000 shares@ US$9.081.8% of flowCommon StockSEC:0000899243-19-030015:0
- 7,500 shares@ US$13.902.0% of flowCommon StockSEC:0000899243-19-030015:1
- 18,916 shares@ US$70.0725.8% of flowCommon StockSEC:0000899243-19-030015:2
- 13,096 shares@ US$65.1316.8% of flowCommon StockSEC:0000899243-19-028345:0
- 7,336 shares@ US$65.529.5% of flowCommon StockSEC:0000899243-19-028345:1
- 800 shares@ US$66.321.0% of flowCommon StockSEC:0000899243-19-028345:2
- 162 shares@ US$40.070.1% of flowCommon StockSEC:0000899243-19-027044:0
- 10,000 shares@ US$9.081.7% of flowCommon StockSEC:0000899243-19-024147:0
- 9,700 shares@ US$12.252.2% of flowCommon StockSEC:0000899243-19-024147:1
- 19,700 shares@ US$60.0921.7% of flowCommon StockSEC:0000899243-19-024147:2
- 313 shares@ US$40.780.2% of flowCommon StockSEC:0000899243-19-015396:0
- 5,000 shares@ US$12.25Common StockSEC:0000899243-19-010836:0
- 570 shares@ US$42.980.4% of flowCommon StockSEC:0000899243-19-000901:0
- 1,425 sharesCommon StockSEC:0000899243-19-000374:0
- 272 shares@ US$42.160.2% of flowCommon StockSEC:0000899243-18-028347:0
- 978 shares@ US$55.450.8% of flowCommon StockSEC:0000899243-18-028347:1
- 7,500 shares@ US$13.901.4% of flowCommon StockSEC:0000899243-18-020579:0
25 of 47 declarations
